These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15205916)

  • 41. Hemophilia B (factor IX deficiency) in a family of German shepherd dogs.
    Feldman DG; Brooks MB; Dodds WJ
    J Am Vet Med Assoc; 1995 Jun; 206(12):1901-5. PubMed ID: 7790304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Preparation and clinical use of a new factor IX concentrate].
    Lopaciuk S; Poszwiński P
    Acta Haematol Pol; 1978; 9(2):107-12. PubMed ID: 665130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful induction of immune tolerance with FIX recombinant in a patient with haemophilia B with inhibitor.
    Soto I; Vicente JM; Corte JR; Urgellés MF; Pinto CR
    Haemophilia; 2004 Jul; 10(4):401-4. PubMed ID: 15230957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Coagulation factor IX inhibitor in hemophilia B].
    Lutze G; Mittler U; Presser HJ; Urbahn H
    Z Med Lab Diagn; 1990; 31(2):113-9. PubMed ID: 2343619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
    Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
    Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvements in factor concentrates.
    Lillicrap D
    Curr Opin Hematol; 2010 Sep; 17(5):393-7. PubMed ID: 20613509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A factor IX-concentrate for the treatment of haemophilia B].
    Suomela H; Myllylä G
    Duodecim; 1971; 87(1):31-8. PubMed ID: 5539580
    [No Abstract]   [Full Text] [Related]  

  • 48. A safe approach to treatment of factor IX-deficient patients. Introduction and overview of treatment.
    Aledort LM
    Semin Hematol; 1991 Jul; 28(3 Suppl 6):1-2. PubMed ID: 1780765
    [No Abstract]   [Full Text] [Related]  

  • 49. Fatal myocardial infarction following therapy with prothrombin complex concentrates in a young man with hemophilia A.
    Sullivan DW; Purdy LJ; Billingham M; Glader BE
    Pediatrics; 1984 Aug; 74(2):279-81. PubMed ID: 6431390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
    Carmassi F; Giannarelli C; De Giorgi A; De Negri F
    Haemophilia; 2007 Jan; 13(1):106-7. PubMed ID: 17212735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The manufacturing process for recombinant factor IX.
    Harrison S; Adamson S; Bonam D; Brodeur S; Charlebois T; Clancy B; Costigan R; Drapeau D; Hamilton M; Hanley K; Kelley B; Knight A; Leonard M; McCarthy M; Oakes P; Sterl K; Switzer M; Walsh R; Foster W
    Semin Hematol; 1998 Apr; 35(2 Suppl 2):4-10. PubMed ID: 9565160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myocardial infarction and other arterial occlusions in hemophilia a patients. A cardiological evaluation of all 42 cases reported in the literature.
    Girolami A; Ruzzon E; Fabris F; Varvarikis C; Sartori R; Girolami B
    Acta Haematol; 2006; 116(2):120-5. PubMed ID: 16914907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coronary artery bypass grafting in a patient with hemophilia B: continuous recombinant factor IX infusion as per the Japanese guidelines for replacement therapy.
    Suzuki T; Kawamoto S; Kumagai K; Adachi O; Kanda K; Ishikawa M; Okitsu Y; Harigae H; Kurosawa S; Saiki Y
    Gen Thorac Cardiovasc Surg; 2016 Aug; 64(8):481-3. PubMed ID: 25523881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of a patient with factor IX deficiency (hemophilia B) with coronary bypass surgery.
    Scharfman WB; Rauch AE; Ferraris V; Burkart PT
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):765-6. PubMed ID: 8469013
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hemophilia B and aortocoronary bypass].
    Dimitrova A; Tsarianski G; Aleksandrov V; Kereshka P; Nachev G; Chirkov A
    Khirurgiia (Sofiia); 1995; 48(1):76-9. PubMed ID: 7474765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Successful management of neurosurgical procedures with continuous infusion of recombinant factor IX in a child with hemophilia B].
    Yamamoto M; Nakadate H; Iguchi U; Masuda H; Sakai H; Ishiguro A
    Rinsho Ketsueki; 2013 Mar; 54(3):300-4. PubMed ID: 23676647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and clinical use of factor IX concentrate PPSB according to Soulier.
    Haanen C; McShine RL; Kunst A
    Vox Sang; 1969 Apr; 16(4):398-411. PubMed ID: 5800593
    [No Abstract]   [Full Text] [Related]  

  • 58. [The successful use of FEIBA for treatment of intracranial hemorrhage in a patient of hemophilia B with inhibitor].
    Taki M; Inagaki M; Tomita Y; Miura T; Saito N; Meguro T; Yamada K
    Rinsho Ketsueki; 1985 Aug; 26(8):1300-5. PubMed ID: 3877831
    [No Abstract]   [Full Text] [Related]  

  • 59. Labor and delivery in a patient with hemophilia B.
    Przkora R; Euliano TY; Roussos-Ross K; Zumberg M; Robicsek SA
    Int J Obstet Anesth; 2011 Jul; 20(3):250-3. PubMed ID: 21641201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cranial hemophilic pseudotumor associated with factor IX deficiency: case report.
    Inoue T; Suzuki Y; Nishimura S; Murakami K; Nishijima M
    Surg Neurol; 2008 Jun; 69(6):647-51; discussion 651. PubMed ID: 18284939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.